Oakbrook Investments’s Bio-Techne TECH Stock Holding History

Oakbrook Investments’s Portfolio TECH Stock Details TECH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-12,000	Closed	-$659K	–	466
2019 Q4	$659K	Buy	+12,000	New	+$630K	0.13%	245
2019 Q3	–	Sell	-18,900	Closed	-$985K	–	645
2019 Q2	$985K	Buy	18,900 +800	+4%	+$40.3K	0.06%	262
2019 Q1	$898K	Buy	18,100 +1,000	+6%	+$45K	0.05%	271
2018 Q4	$619K	Buy	17,100 +12,300	+256%	+$514K	0.04%	326
2018 Q3	$245K	Buy	+4,800	New	+$213K	0.01%	583
2018 Q2	–	Sell	-13,080	Closed	-$494K	–	610
2018 Q1	$494K	Buy	+13,080	New	+$462K	0.03%	356
2016 Q4	–	Sell	-7,700	Closed	-$211K	–	592
2016 Q3	$211K	Buy	+7,700	New	+$211K	0.01%	519
2014 Q1	–	Sell	-14,800	Closed	-$350K	–	624
2013 Q4	$350K	Sell	14,800 -2,000	-12%	-$43.3K	0.01%	466
2013 Q3	$336K	Sell	16,800 -5,200	-24%	-$98.7K	0.01%	474
2013 Q2	$380K	Buy	+22,000	New	+$365K	0.01%	491

Other funds holding TECH

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

BCM

Brown Capital Management Baltimore, Maryland $500M AUM 25.3% 1-Year Est. Return

BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return

ACM

Atlanta Capital Management Atlanta, Georgia $22.5B AUM 9.67% 1-Year Est. Return

Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $3.89B AUM 16.15% 1-Year Est. Return

MPI

Mairs & Power Inc St Paul, Minnesota $10.9B AUM 27.5% 1-Year Est. Return

JSP

Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return

Oakbrook Investments's TECH Position: Q1 2020 in Review

Oakbrook Investments sold out of Bio-Techne (TECH) in Q1 2020, closing a stake of 12,000 shares — an estimated $659K sold.

Oakbrook Investments first reported a position in TECH in Q2 2013 and held it in 10 quarters. The position peaked at $985K in Q2 2019. 368 funds tracked by Wall St. Rank hold TECH as of Q1 2020.

Oakbrook Investments reported no remaining Bio-Techne position as of Q1 2020 after selling out during the quarter.
Oakbrook Investments sold 12,000 Bio-Techne shares in Q1 2020, an estimated $659K.
Oakbrook Investments first reported a position in Bio-Techne in Q2 2013 and held it in 10 quarters.
Oakbrook Investments's Bio-Techne position peaked at $985K in Q2 2019.
368 funds tracked by Wall St. Rank held Bio-Techne as of Q1 2020.

Based on Oakbrook Investments's 13F filing for Q1 2020, filed 22 Apr 2020.